Navigation Links
FDA Approves Administration of LEXIVA(R) with Lower Dose of 'Boosting' Medication Ritonavir
Date:10/12/2007

n occur in patients taking LEXIVA. Rarely, rashes were severe or life threatening. Opportunistic infections can develop when patients have HIV and their immune system is weak. It is very important that patients see their healthcare provider regularly while taking LEXIVA to discuss any side effects or concerns. Most common side effects in clinical studies were diarrhea, headache, nausea, rash, and vomiting. In most cases, these side effects did not cause people to stop taking their medicine.

For full prescribing information for LEXIVA, please visit http://www.LEXIVA.com.

LEXIVA was co-discovered by GlaxoSmithKline and Vertex Pharmaceuticals Incorporated.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies and an industry leader in HIV research and therapies. The company is engaged in basic research programs designed to investigate new targets to treat HIV. For full prescribing information please go to http://www.LEXIVA.com.

GSK's Bridges to Access program can help provide qualified individuals with access to GSK's antiretroviral medications, as well as help identify insurance or other support for medications. Patients may be eligible for this program if they are not eligible for prescription drug benefits through any other private or public insurer, payer or program. In 2004, GlaxoSmithKline donated more than $372.5 million worth of prescription drugs to 475,000 patients. For more information, visit http://www.bridgestoaccess.gsk.com or call 1-866-PATIENT.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products bot
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Lowering the fear factor for entrepreneurs, intra-preneurs
9. Immune boosting beverage relying on Milwaukee firms packaging technology
10. GE Healthcare develops digital medication system

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., Neb., Nov. 5 Transgeno...ed financial results for the quarter ended Septemb...resented in the tables that follow. ,, Third Q... of $366,000 or $0.01 per share for the third quar...or $0.01 per share for the third quarter of 2008. ...
(Date:11/5/2009)...WORTH, Texas, Nov. 5 Wou...d today that it has entered into a Letter of Inten...tual Health Technologies, Inc. (OTC Bulletin Board...000,000 in cash and debt, 4,000,000 shares of WNDM... WNDM on the Veriscrip technology being acquired f...
(Date:11/5/2009)...N, Texas, Nov. 5 SpineSmith Partne...Inc. to co-develop a unique scaffold that mimics t...g evaluation of several commercial products by Spi... company believes the GenOsteo scaffold represents...tes a unique and ideal environment for the deliver...
(Date:11/5/2009)... LASIK Surgery and vision correction...ctory were actively involved at the recently concl...Annual Meeting in San Francisco, California. Dr. S...r. Jonathan Davidorf, MD, Dr. Peter Rapoza, MD, Dr... R. Wayne Bowman, MD, Dr. Edward Manche, MD, and D...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...n beginning a brand new startup or building a smal...the challenges of attracting, and more importantly...ncentive for all employees to share in the wealth-... successful companies during the last fifteen year...as are being discussed and implemented by the Fort...
...always, these are general rules, and any good entr...nique. At the same time, in the last 3.5 years wev... performed about 750 basic reviews and about 100 d...d more than a dozen investments (and a couple misf...s, and a final reminder of why were doing this in ...
...nds to be used for labs, technology, research, com...tary Tommy G. Thompson today announced that the De...ilable an additional $1.4 billion to increase the ... respond to terrorism and other public health emer...lion, of which almost $16 Million will come from C...
Other Biology Technology:Learning from the Big Guys 2"For Angels Only...When to say No... 2"For Angels Only...When to say No... 3Wisconsin to Receive $25 Million for Bioterrorism 2
(Date:11/4/2009)... GenVault Corporation, the leader in ambient tempe... medicine and identification, today announced that..., will be presenting at the BIOCOM Investor Confer...olla, CA. ,, During the presentation, Dr. Welli... with recent customer, technical and strategic dev...
(Date:11/4/2009)...ity of North Carolina at Chapel Hill School of Med...sco have developed and experimentally tested a tec... drugs. , The researchers developed a computatio...s of all known drugs are to the naturally occurrin...se targets within the cell. In a study published t...
(Date:11/3/2009)...s greatest wines are the result of a threefold syn...ng called the "terroir" -- a term often defined as...ts will discuss terroir with an emphasis on soil s...sburgh. "Terroir: Winegrapes and the Environment"... Meetings of the American Society of Agronomy (ASA...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Study points to new uses, unexpected side effects of already existing drugs 2Great wines come from great soils 2Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 1Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 2Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 3Professional Pricing Society Announces Educational Partnership with Vendavo 26quot 3BPPS Accepting Vendavo Pricing Knowledge Series Awards to Cert 14536 1Professional Pricing Society Announces Educational Partnership with Vendavo 26quot 3BPPS Accepting Vendavo Pricing Knowledge Series Awards to Cert 14536 2Professional Pricing Society Announces Educational Partnership with Vendavo 26quot 3BPPS Accepting Vendavo Pricing Knowledge Series Awards to Cert 14536 3Professional Pricing Society Announces Educational Partnership with Vendavo 26quot 3BPPS Accepting Vendavo Pricing Knowledge Series Awards to Cert 14536 4Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 1Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 2Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 3
...gets identified by a Spanish research team may hol...disease. A new study published in Disease Models ... the cellular signals which cause one treatment fo... , One of the most devastating aspects of kidney f...imen. Normally, healthy kidneys take on the role ...
...lished in the open access journal PLoS Biology, ...gies to show the surprising result that the surviv...ers was similar, despite the presence of an extens...chers have used tags to follow larger ocean dwelle... and to follow migrations of mature salmon along m...
...Mich.---Wearing masks and using alcohol-based hand... by as much as 50 percent, a landmark new study su...icacy of non-pharmaceutical interventions in contr...setting, researchers at the University of Michigan...tudent subjects from seven U-M residence halls dur...
Other Biology News:Scientists identify cell changes leading to impaired 'artificial kidney' function 2Research challenges conventional notions about salmon survival 2Masks, hand washing, prevent spread of flu-like symptoms by up to 50 percent 2Masks, hand washing, prevent spread of flu-like symptoms by up to 50 percent 3
Rabbit Anti-Bacterial HISTIDASE Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Human REDD1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-HAX1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Goat Anti-Human FACTOR 8RELATED ANTIGEN Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: